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Abstract
Actinomycosis  is  a  rare  disorder  caused  by  an  anaerobic  gram-positive  bacillus  (Actino-
myces), predominantly  by  the  Actinomyces  israelii  species.  Only  20%  of  cases  show  an
abdominal manifestation,  the  appendix  and  ileocecal  valve  being  the  most  frequent  loca-
tions. Deﬁnitive  diagnosis  is  based  on  microbiological  cultures,  microscopy  or  macroscopy
examination.  Nevertheless,  histological  examination  of  the  percutaneous  biopsy  and  blood
microbiological  cultures  are  rarely  positives.  Preoperative  diagnosis  is  hampered  by  the  lack
of speciﬁc  clinical  and  imaging  manifestations,  which  often  mimic  malignancy.  The  rate  of
preoperative  diagnosis  is  less  than  10%,  however,  the  outcome  is  excellent,  with  a  low  mortality
rate. The  authors  describe  the  case  of  a  patient  who  was  diagnosed  with  primary  hepatic
actinomycosis  only  by  a  histological  examination  of  the  surgical  specimen  of  left  hepatectomy
extended to  segments  V  and  VIII,  for  suspected  malignant  lesion.  This  case  demonstrates  the
difﬁculties  in  diagnosing  hepatic  actinomycosis.
© 2014  Sociedade  Portuguesa  de  Gastrenterologia.  Published  by  Elsevier  España,  S.L.U.  All  rights
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Actinomicose  Hepática
Resumo
A  actinomicose  é  uma  entidade  clínica  rara,  causada  por  uma  bactéria  anaeróbia  gram-
positiva (Actinomyces),  predominantemente  da  espécie  Actinomyces  israelii.  Apenas  em
20% dos  casos  apresenta  manifestac¸ão  abdominal,  sendo  o  apêndice  e  a  válvula  ileocecal  as
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localizac¸ões  mais  frequentes.  Os  autores  descrevem  o  caso  de  um  doente  em  que  foi  feito  o
diagnóstico de  actinomicose  hepática  primária  apenas  pelo  exame  histológico  da  pec¸a  cirúrgica
de hepatectomia  esquerda  alargada  aos  segmentos  V  e  VIII,  por  suspeita  de  lesão  maligna.
Este caso  demonstra  a  diﬁculdade  diagnóstica  da  actinomicose  hepática.  O  diagnóstico  pré-
operatório é  diﬁcultado  pela  falta  de  manifestac¸ões  clínicas  e  imagiológicas  especíﬁcas,  muitas
vezes simulando  doenc¸a  maligna.  Para  além  disso,  as  culturas  e  o  exame  histológico  de  biópsia
percutânea  raramente  são  positivos.  A  taxa  de  diagnóstico  pré-operatório  é  inferior  a  10%,
contudo o  prognóstico  é  bom,  apresentando  uma  taxa  de  mortalidade  de  cerca  de  7,6%.
© 2014  Sociedade  Portuguesa  de  Gastrenterologia.  Publicado  por  Elsevier  España,  S.L.U.  Todos
os direitos  reservados.
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y. Introduction
ctinomycosis  is  a  rare  chronic,  granulomatous  infection
aused  by  gram-positive  bacilli  of  the  genus  Actinomyces.
here  are  13  different  species,  but  only  6  are  associated
ith  human  disease.  The  most  common  pathogenic  specie  in
umans  is  Actinomyces  israelli.1 These  microorganisms  are
rominent  among  the  commensal  ﬂora  of  the  oropharynx,
astrointestinal  tract  and  female  genital  tract.2 Actino-
ycosis  is  most  frequently  associated  with  cervicofacial
nfection.  Only  20%  of  the  cases  present  abdominal  mani-
estations,  the  appendix  and  the  ileocecal  region  being  the
ost  common  affected  sites.3 Liver  involvement  occurs  in
5%  of  abdominal  infections  representing  5%  of  all  cases  of
ctinomycosis,4 and  it  is  usually  secondary  to  other  intraab-
ominal  infection.5 The  insidious  course  with  nonspeciﬁc
ymptoms  makes  the  diagnosis  of  this  condition  a  challeng-
ng.
. Case report
 38-year-old  man  was  referred  to  the  Gastroenterology
epartment  for  a  history  of  epigastric  pain  refractory  to
roton  pump  inhibitor  therapy.  He  reported  a  2  years  his-
ory  of  night  sweats  and  weight  loss  (12%  of  body  weight).
he  patient  denied  other  dyspeptic  complaints,  hemateme-
is  or  melena  and  systemic  symptoms,  including  fever,
alaise  and  anorexia.  His  past  medical  history  included  duo-
enal  ulcer  treated  with  proton  pump  inhibitor,  3  years
go.  No  history  of  previous  surgeries.  He  was  medicated
ith  omeprazole  20  mg  qd  on  regular  basis.  The  physical
xamination  was  normal.  Laboratory  tests  evidenced  nor-
ocytic/normochromic  anemia  (Hb  12  g/dl,  normal:  14--18),
eukocytosis  (15.21  ×  103/uL,  normal:  4--11.5)  with  neu-
rophilia  (80%,  normal:  50--70),  elevation  of  inﬂammatory
arameters  (C-reactive  protein:  2.46  mg/dl  (normal  0--0.3)
nd  erythrocyte  sedimentation  rate  33  mm  (normal  0--15)
nd  mild  elevation  of  alkaline  phosphatase  170  U/L  (normal:
0--129).  The  remaining  analytical  assessment  was  normal,
ncluding  tumor  markers  and  human  immunodeﬁciency  virus
ntibody  test.  Infection  by  Mycobacterium  tuberculosis  was
xcluded.  Upper  gastrointestinal  endoscopy  revealed  pyloric
ubstenosis,  yet  allowing  the  passage  of  the  endoscope
t
m
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to  the  duodenum,  probably  resulting  from  previous  duo-
enal  ulcer.  Biopsies  were  performed  in  normal  mucosa,
hich  revealed  chronic  gastritis  due  to  Helicobacter  pylori.
astroduodenal  transit  was  normal.  An  abdominal  ultra-
ound  identiﬁed  in  segment  IV  of  the  liver  a  pseudonodular
esion,  hypoechoic,  heterogeneous  with  partially  undeﬁned
imits  with  45  ×  33  mm  (Fig.  1).  A  contrast-enhanced  com-
uted  tomography  (CT)  scan  showed  the  same  lesion,
resenting  low  enhanced  in  the  arterial  phase,  with  pro-
ressive  enhanced  in  the  late  phase  (Fig.  2).  To  further
haracterize  the  lesion  a  magnetic  resonance  imaging  (MRI)
as  performed  revealing  the  same  nodular  lesion  with
obulated  and  undeﬁned  limits  of  4  cm  in  its  greatest  diam-
ter,  hypointense  signal  on  T1  and  hyperintense  signal  on
2  (Fig.  3).  These  images  were  suggestive  of  cholangio-
arcinoma  but  secondary  deposit  cannot  be  excluded.  A
T-guided  liver  biopsy  revealed  an  inﬂammatory  pseudotu-
or/inﬂammatory  myoﬁbroblast  tumor  (Fig.  4).  The  patient
as  then  referred  to  referral  Hospital  in  hepatobiliary
urgery  where  he  underwent  left  hepatectomy  extended  to
egments  V  and  VIII.  The  histological  examination  of  surgical
issue  demonstrated  abscesses  due  to  Actinomyces  (Fig.  5).
he  patient  was  treated  with  doxycycline  for  three  months.
ighteen  months  after  the  surgery,  he  is  completely  asymp-
omatic.
. Discussion
ctinomycosis  is  a  rare  cause  of  intra-abdominal  infection.
he  main  risk  factors  associated  with  this  condition  are
oss  of  integrity  of  the  gastrointestinal  mucosa,  previous
bdominal  surgery,  intra-abdominal  infection,  gastrointesti-
al  foreign  body  and  imunossupression.5,6 Liver  involvement
ccurs  by  hematogenous  spread  via  the  portal  vein  from
ither  a  mucosal  injury  or  infection.7 Sharma  et  al.  con-
ucted  a study  which  found  that  about  17.5%  of  cases
f  abdominal  actinomycosis  were  associated  with  previous
bdominal  or  pelvic  procedures  performed  within  the  last
ear.8 In  this  case,  the  time  between  diagnosis  and  the  ini-
iation  of  duodenal  ulcer  was  one  year.  Despite  the  known
ajor  risk  factors,  hepatic  actinomycosis  is  cryptogenic  in
0%  of  cases  and4,6 polymicrobial  in  33%.9 As  in  our  case,
here  is  male  predominance  (70--74%)  in  immunocompetent
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Figure  1  Abdominal  ultrasound:  pseudonodular  lesion,  hypoechoic,  heterogeneous  and  partially  undeﬁned  in  segment  IV  of  the
liver.
Figure  2  Contrast-enhanced  computed  tomography  scan:  low  enhanced  lesion  in  the  arterial  phase  (A),  with  progressive  enhanced
in the  late  phase  (B).
its,  
a
lFigure  3  MRI:  nodular  lesion  with  lobulated  and  undeﬁned  lim
adults,  aged  between  30  and  50  years.4,5,8 Due  to  an
insidious  course,  it  takes  several  weeks  to  months9,10 of
symptoms  to  make  the  diagnosis  with  a  range  of  4  days
to  18  months  until  presentation.10 In  addition,  both  clinical
and  laboratory  manifestations  are  nonspeciﬁc.  The  most  fre-
quent  symptoms  are  fever  (83.3%),  abdominal  pain  (74.5%)
a
S
v
dhypointense  signal  on  T1  (A)  and  hyperintense  signal  on  T2  (B).
nd  weight  loss  (50.9%).11,12 Analytically  presents  with
eukocytosis  (75%),  elevated  alkaline  phosphatase  (83.3%)
6,8,13nd  erythrocyte  sedimentation  rate, as  in  this  case.
ome  studies  have  demonstrated  an  association  with  ele-
ated  levels  of  CA  19.9,  but  with  lower  values  than  those
escribed  for  malignant  conditions.14
22  
Figure  4  Histology  of  liver  fragment:  inﬂammatory  pseudo-
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tumor  (hematoxylin  and  eosin  100×).
In  imaging  studies,  particularly  in  ultrasound,  CT  and
RI,  hepatic  actinomycosis  presents  with  a  single  hypodense
esion  in  66%  of  cases.  In  the  remaining  33%  it  may  present  as
ultiple  hepatic  abscesses.2,5,10,15,16 Thus,  it  is  necessary  to
istinguish  it  from  both  malignant  lesions  (primary  or  sec-
ndary  tumor  deposits)  and  benign  lesions  (cystic  lesions,
yogenic  abscesses,  amebiasis  or  echinococcosis),5 taking
nto  account  the  characteristics  of  the  lesion.  In  about
4.7%  of  the  cases  mimics  a  malignant  lesion5,9 and  the
ight  lobe  is  the  most  affected  (56.5%).2,5,16 MRI  is  charac-
erized  by  hypointense  signal  on  T1-and  hyperintense  signal
n  T2.17 In  our  case,  the  lesion  presents  features  of  malig-
ancy,  including  heterogeneous  content  and  undeﬁned  limits
hich  associated  with  MRI  study  requires  differential  diag-
osis  with  cholangiocarcinoma,  despite  the  young  age  of  the
atient.  The  diagnosis  of  hepatic  abscess  was  also  consid-
red  because  the  patient  had  fever  for  a  long  period,  how-
ver  the  imagiologic  studies  did  not  support  this  hypothesis.
Deﬁnitive  diagnosis  is  based  on  blood  cultures,6,7,9
icroscopy  (percutaneous  biopsy,  laparoscopic  or  surgical
P
d
a
igure  5  Histological  examination  allowed  the  observation  of  ab
ocytes and  necrotic  tissue  is  surrounded  by  a  band  of  ﬁbrous  conne
lugs of  Actinomyces  (A  --  hematoxylin  and  eosin,  magniﬁcation  5×)
o aggregates  of  Actinomyces  were  identiﬁed  (B  and  C  --  PAS  5×  andF.  Ávila  et  al.
issue  specimens)  and  macroscopic  examination,  which
eveal  basophilic  ﬁlament  aggregates  and  yellow  ‘‘sulfur
ranules’’.4,6,9 In  our  patient  histological  diagnosis  of  inﬂam-
atory  pseudotumor  probably  corresponds  to  a  fragment
f  the  capsule  of  abscess,  which  is  constituted  by  ﬁbrous
onnective  tissue  with  focal  inﬂammatory  inﬁltrate.
The  rate  of  preoperative  diagnosis  is  less  than  10%,4,18
espite  advanced  imaging  techniques.  In  addition,  blood
ultures  are  positive  in  only  15.4%  of  the  cases4,8 and  per-
utaneous  biopsy  diagnosis  is  not  always  conclusive.
Therapeutic  options  available  are  antibiotics,  surgical
esection  and  percutaneous  drainage  either  alone  or  in
ombination.6,9 There  are  no  current  guidelines  available,
articularly  in  what  pertains  the  indication  for  surgery.
n  the  literature,  are  not  described  guidelines  for  ther-
py,  particularly  for  surgery  indication.9 Early  initiation  of
ntibiotics  is  usually  effective.8 Surgery  should  be  reserved
or  the  cases  in  which  percutaneous  drainage  is  not  pos-
ible  and  for  larger  lesions  in  which  there  is  a  greater
mount  of  necrotic  tissue  and  therefore  lower  penetrance  of
ntibiotic.10
The  recommended  antibiotics  are  a  penicillin  derivative,
etracycline  or  clindamycin.6 Duration  of  treatment  is  vari-
ble  with  courses  lasting  from  3  to  6  months.5,10 Despite  the
sual  delay  in  making  the  diagnosis  and  consequently  in  ini-
iating  therapy,  the  outcome  is  excellent,  with  a  mortality
ate  of  7.6%.2,5,9,16,19
In  conclusion,  primary  hepatic  actinomycosis  is  a  rare
isease  and  difﬁcult  to  diagnosis,  since  its  clinical  and  ana-
ytical  presentation  is  nonspeciﬁc.  The  differential  diagnosis
s  extensive  encompassing  both  benign  and  malignant  con-
itions.  However,  it  has  a  good  prognosis  after  appropriate
reatment.rotection  of  human  and  animal  subjects.  The  authors
eclare  that  no  experiments  were  performed  on  humans  or
nimals  for  this  study.
cesses  in  several  areas.  A  central  zone  with  neutrophil  granu-
ctive  tissue  that  constitutes  the  abscess  capsule,  showing  the
.  At  higher  magniﬁcation,  ﬁlamentous  structures  corresponding
 40×  magniﬁcation  respectively).
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